RxDoctor Payments Data

Chris Chacko, MD

Otolaryngology · Evansville, INNPI 1679731665

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (52.8%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Stryker at 30.3% of the total. Reporting peaked in 2020 at $2,265 and has fallen 78.3% since, to $491 in 2025.

$7,486in general payments, 2019–2025

Across 63 payments — averaging $118.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Smith+Nephew$2K
  • Aerin Medical Inc.$1K
  • Medical Device Business Services, Inc.$858
  • Inspire Medical Systems, Inc.$374
  • Acclarent, Inc$283
  • plus $530 from 8 others

What the payments were for

  • Travel & lodging$3,95253%
  • Food & beverage$3,51247%
  • Gifts$210%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,486 in reported general payments places this provider in the 85th percentile of 193 otolaryngology providers in Indiana.

See all otolaryngology providers in Indiana

Medicare billing

Part B allowed, 2024
$38,370
Medicare patients
106
Services billed
296

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ofloxacin29$1,099
Ipratropium Bromide28$567
Mometasone Furoate18$299
Omeprazole11$232

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Evansville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →